1.
Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain.
Int J Pharm
; 647: 123549, 2023 Nov 25.
Article
En
| MEDLINE | ID: mdl-37890645
2.
Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors.
Int J Pharm
; 631: 122537, 2023 Jan 25.
Article
En
| MEDLINE | ID: mdl-36572260